Immunic, Inc. (IMUX) Earning

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.18
Day's range
$1.27

Immunic Inc Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2026 7 -$1.26 -$0.19 -$0.69
Q2 2026 7 -$1.92 -$0.53 -$0.98
Q3 2026 3 -$1.02 -$1.02 -$1.02
Q4 2026 3 -$1.02 -$1.02 -$1.02
Q1 2027 3 -$0.92 -$0.92 -$0.92
Q2 2027 2 -$0.94 -$0.94 -$0.94
Q3 2027 2 -$0.96 -$0.96 -$0.96
Q4 2027 2 -$0.99 -$0.99 -$0.99
Q1 2028 3 $0.83 $0.83 $0.83
Q2 2028 6 $1.53 $1.53 $1.53
Q3 2028 5 $1.50 $1.50 $1.50
Q4 2028 5 $1.53 $1.53 $1.53

Immunic Inc Earnings Date And Information

Immunic Inc last posted its earnings results on Wednesday, May 13th, 2026. The company reported $-1.08 earnings per share for the quarter, missing analysts' consensus estimates of $-0.71 by $0.37. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Immunic Inc has generated $-6 earnings per share over the last year ($-6.24 diluted earnings per share) and currently has a price-to-earnings ratio of -3.74. Immunic Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.

Immunic Inc Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
05/13/2026 Q1 2026 -$0.71 -$1.08 -0.37 $0 $0
02/26/2026 Q4 2025 -$0.90 -$1.60 -0.7 $0 $0
11/13/2025 Q3 2025 -$0.18 -$1.30 -1.12 $0 $0
08/07/2025 Q2 2025 -$0.18 -$2.00 -1.82 N/A $0
05/15/2025 Q1 2025 -$0.25 -$2.50 -2.25 N/A $0
03/31/2025 Q4 2024 -$0.22 -$2.80 -2.58 $6.00 K $0
11/07/2024 Q3 2024 -$0.22 -$2.40 -2.18 $6.00 K $0
08/08/2024 Q2 2024 -$0.23 -$2.10 -1.87 N/A $0
05/08/2024 Q1 2024 -$0.27 -$3.00 -2.73 N/A $0
02/22/2024 Q4 2023 -$0.51 -$4.80 -4.29 N/A $0
09/29/2023 Q3 2023 N/A -$5.10 N/A N/A $0
08/03/2023 Q2 2023 -$0.52 -$5.40 -4.88 N/A $0
05/11/2023 Q1 2023 -$0.54 -$5.30 -4.76 N/A $0
02/23/2023 Q4 2022 -$0.82 -$27.80 -26.98 N/A $0
11/03/2022 Q3 2022 -$0.64 -$7.30 -6.66 N/A $0
08/04/2022 Q2 2022 -$0.72 -$7.20 -6.48 N/A $0
05/10/2022 Q1 2022 -$0.80 -$7.20 -6.4 N/A $0
02/24/2022 Q4 2021 -$0.73 -$8.40 -7.67 N/A $0
11/04/2021 Q3 2021 -$0.81 -$7.60 -6.79 N/A $0
08/06/2021 Q2 2021 -$0.72 -$8.20 -7.48 N/A $0

Immunic Inc Earnings: FAQ's

The conference call for Immunic Inc's latest earnings report can be listened to online.

The conference call transcript for Immunic Inc's latest earnings report can be read online.

Immunic Inc (:IMUX) has a recorded net income of $-97,172,000.Immunic Inc has generated $-6.24 earnings per share over the last four quarters.

Immunic Inc (:IMUX) has a price-to-earnings ratio of -3.74 and price/earnings-to-growth ratio is -0.07.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED